Table 4 Comparison between cannulation success and failure
Cannulation failure | No (n = 269) | Yes (n = 17) | p value |
|---|---|---|---|
Papilla type | 0.037* | ||
1 | 116 (43.12%) | 2 (11.76%) | |
2 | 22 (8.18%) | 3 (17.65%) | |
3 | 56 (20.82%) | 7 (41.18%) | |
4 | 75 (27.88%) | 5 (29.41%) | |
Age | 65 (53–75) | 71 (65.5–85.5) | 0.010* |
Gender-Male | 142 (52.79%) | 8 (47.06%) | 0.835 |
Indication | 0.084 | ||
Stone | 200 (74.35%) | 9 (52.94%) | |
Cancer | 41 (15.24%) | 6 (35.29%) | |
Other | 28 (10.41%) | 2 (11.76%) | |
Diabetes a | 74 (27.51%) | 2 (11.76%) | 0.255 |
Hypertension | 123 (45.72%) | 7 (41.18%) | 0.909 |
CVA a | 16 (5.95%) | 3 (17.65%) | 0.093 |
CRI a | 27 (10.04%) | 1 (5.88%) | 1.000 |
COPD a | 7 (2.60%) | 2 (11.76%) | 0.094 |
CAD a | 17 (6.32%) | 1 (5.88%) | 1.000 |
Cirrhosis a | 14 (5.20%) | 0 (0.00%) | 1.000 |
PAD | |||
0 | 153 (56.88%) | 13 (76.47%) | 0.215 |
2 | 32 (11.90%) | 2 (11.76%) | |
3 | 84 (31.23%) | 2 (11.76%) | |
Platelet | 215 (163–287) | 171 (123–269) | 0.159 |
PT | 10 (10–10.9) | 11 (10.15–11.65) | 0.103 |
APTT | 28 (26.1–29.7) | 30 (27.4–31.6) | 0.058 |
GOT | 105 (41.75–220.75) | 110 (50.25–170.25) | 0.837 |
GPT | 122 (47–290.75) | 85 (29–185.5) | 0.190 |
Bilirubin | 3 (1.2–5.85) | 3 (1.3–8.5) | 0.754 |
Creatinine | 1 (0.67–1.02) | 1 (0.8–1.32) | 0.100 |